Blenrep OverviewBelantamab mafodotin, sold under the brand name Blenrep, is a medication for the treatment of relapsed and refractory multiple myeloma. The most common adverse reactions include keratopathy (corneal epithelium change on eye exam), decreased visual acuity, nausea, blurred vision, pyrexia, infusion-related reactions, and fatigue. Belantamab mafodotin is a humanized IgG1κ monocl...
Read more Blenrep Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Belantamab_mafodotin
Recent Blenrep Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 2.5mg/kg
NDC Database Records for Blenrep: (1 result)Sorted by National Drug Code
- 0173-0896 Blenrep 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline LLC